TradingKey

mehr Informationen über Kamada Ltd Unternehmen

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Unternehmensinformationen

BörsenkürzelKMDA

Name des UnternehmensKamada Ltd

IPO-datumAug 01, 2005

CEOMr. Amir London

Anzahl der mitarbeiter374

WertpapierartOrdinary Share

GeschäftsjahresendeAug 01

Addresse2 Holtzman St., Science Park

StadtREHOVOT

BörseNASDAQ Global Select Consolidated

LandIsrael

Postleitzahl7670402

Telefon97289406472

Websitehttps://www.kamada.com/

BörsenkürzelKMDA

IPO-datumAug 01, 2005

CEOMr. Amir London

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Leon Yehuda Recanati

Director

631.14K

--

Mr. David Tsur

Deputy Chairman of the Board

607.93K

--

Mr. Amir London

Chief Executive Officer

61.88K

+3.12%

Ms. Orit Pinchuk

Vice President - Regulatory Affairs and Quality R&D

12.13K

--

Ms. Yael Brenner

Vice President - Quality

6.27K

--

Mr. Barak Bashari

Vice President - Operations

--

Dr. Michal Stein

Vice President and Medical Director for Immunology

--

DR. Michal Ayalon

Vice President - Research & Development

--

Dr. Abraham (Avri) Havron, Ph.D.

Independent Director

--

Dr. Estery Giloz-Ran

Independent Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Leon Yehuda Recanati

Director

631.14K

--

Mr. David Tsur

Deputy Chairman of the Board

607.93K

--

Mr. Amir London

Chief Executive Officer

61.88K

+3.12%

Ms. Orit Pinchuk

Vice President - Regulatory Affairs and Quality R&D

12.13K

--

Ms. Yael Brenner

Vice President - Quality

6.27K

--

Mr. Barak Bashari

Vice President - Operations

--

Umsatzaufteilung

Währung: USDAktualisiert: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Keine Daten

Nach RegionUSD

Name

Umsatz

Anteil

U.S.A

30.16M

68.51%

Israel

5.35M

12.16%

Latin America

4.61M

10.48%

Canada

3.04M

6.90%

Asia

790.00K

1.79%

Europe

70.00K

0.16%

Nach Geschäftsbereich

Nach Region

Keine Daten

Aktionärsstatistik

Aktualisiert: Fri, May 16

Aktionäre

Aktionärstypen

Aktionäre

Anteil

First Israel Mezzanine Investors Ltd.

38.40%

Gov Financial Holdings, Ltd.

4.87%

Phoenix Investment and Finances Ltd

2.88%

Renaissance Technologies LLC

1.41%

Recanati (Leon Yehuda)

1.10%

Other

51.34%

Aktionäre

Anteil

First Israel Mezzanine Investors Ltd.

38.40%

Gov Financial Holdings, Ltd.

4.87%

Phoenix Investment and Finances Ltd

2.88%

Renaissance Technologies LLC

1.41%

Recanati (Leon Yehuda)

1.10%

Other

51.34%

Aktionärstypen

Aktionäre

Anteil

Private Equity

38.40%

Corporation

4.87%

Investment Advisor

4.01%

Hedge Fund

2.51%

Individual Investor

2.34%

Investment Advisor/Hedge Fund

2.14%

Research Firm

1.63%

Other

44.08%

Institutionelle Beteiligung

Aktualisiert: Tue, Jul 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q2

80

32.16M

55.93%

-1.18M

2025Q1

80

31.87M

55.42%

-1.29M

2024Q4

72

32.96M

57.32%

-768.38K

2024Q3

87

33.30M

57.92%

-790.28K

2024Q2

91

33.17M

57.70%

-784.97K

2024Q1

93

32.46M

56.47%

-1.61M

2023Q4

102

32.56M

56.63%

-1.63M

2023Q3

106

34.53M

63.12%

+10.56M

2023Q2

108

21.99M

49.05%

-2.19M

2023Q1

111

22.14M

49.40%

-1.73M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

First Israel Mezzanine Investors Ltd.

22.08M

38.4%

--

Dec 31, 2024

Gov Financial Holdings, Ltd.

2.80M

4.87%

-55.95K

-1.96%

Dec 31, 2024

Phoenix Investment and Finances Ltd

1.65M

2.88%

-178.00K

-9.71%

Mar 31, 2025

Renaissance Technologies LLC

808.30K

1.41%

-23.61K

-2.84%

Mar 31, 2025

Recanati (Leon Yehuda)

631.14K

1.1%

--

Dec 31, 2024

Wells Fargo Advisors

608.59K

1.06%

-22.10K

-3.50%

Mar 31, 2025

Tsur (David)

607.93K

1.06%

--

Dec 31, 2024

Millennium Management LLC

448.19K

0.78%

+130.29K

+40.98%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

412.01K

0.72%

+9.32K

+2.31%

May 31, 2025

More Investment House Ltd.

330.35K

0.57%

-168.57K

-33.79%

Mar 31, 2025

Verbundene ETFs

Aktualisiert: Sat, Aug 2

Name

Anteil

ARK Israel Innovative Technology ETF

1.69%

DFA Dimensional International Small Cap Value ETF

0.01%

DFA Dimensional International Small Cap ETF

0.01%

Schwab International Small-Cap Equity ETF

0%

Avantis International Equity ETF

0%

Dimensional International Core Equity Market ETF

0%

DFA Dimensional International Core Equity 2 ETF

0%

Vanguard Total World Stock Index Fund

0%

Vanguard ESG International Stock ETF

0%

ARK Israel Innovative Technology ETF

Anteil1.69%

DFA Dimensional International Small Cap Value ETF

Anteil0.01%

DFA Dimensional International Small Cap ETF

Anteil0.01%

Schwab International Small-Cap Equity ETF

Anteil0%

Avantis International Equity ETF

Anteil0%

Dimensional International Core Equity Market ETF

Anteil0%

DFA Dimensional International Core Equity 2 ETF

Anteil0%

Vanguard Total World Stock Index Fund

Anteil0%

Vanguard ESG International Stock ETF

Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split

Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

Kamada Ltd

7.150USD

Kamada Ltd

7.150

Übersicht

Unternehmen

Finanzen